Valvano Maria Rosa

Si occupa di: epidemiologia genetica e statistica genetica, studi di associazione, linkage analysis, stima della dimensione campionaria, correlazione genotipo/fenotipo, analisi di sopravvivenza, analisi dei profili di espressione dei geni e dei miRNA, meta-analisi.

linkedin researchgate

Informazioni aggiuntive

  • Pubblicazioni Scientifiche:

    Totale pubblicazioni a partire dal 2011: 54


    Anno

    2018; 8(1): 16389

    Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer.

    Tavano F, Gioffreda D, Valvano MR, Palmieri O, Tardio M, Latiano TP, Piepoli A, Maiello E, Pirozzi F, Andriulli A


    2018; 6(2): 225-237

    Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.

    Morisco F, Granata R, Camera S, Ippolito A, Milella M, Conti F, Masetti C, Smedile A, Tundo P, Santantonio T, Valvano MR, Termite A, Gatti P, Messina V, Iacobellis A, Librandi M, Caporaso N, Andriulli A, ITAL-C consortium.


    2018; 53(): 79-84

    Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas.

    Andriulli A, Stroffolini T, Mariano A, Valvano MR, Grattagliano I, Ippolito AM, Grossi A, Brancaccio G, Coco C, Russello M, Smedile A, Petrini E, Martini S, Gaeta GB, Rizzetto M


    2017; ():

    Hepatitis C Virus Clearance in Older Adults.

    Ippolito AM, Iacobellis A, Milella M, Conti F, Messina V, Valvano MR, Niro GA, Morisco F, Barone M, Termite AP, Brancaccio G, Andriulli A


    2017; 45(9): 1193-1200

    Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis.

    Guarino M, Morisco F, Valvano MR, Ippolito AM, Librandi M, Andriulli N, Greco M, Amoruso A, Iacobellis A, Niro G, Caporaso N, Andriulli A


    2017; 49(9): 1022-1028

    HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.

    Ippolito AM, Milella M, Messina V, Conti F, Cozzolongo R, Morisco F, Brancaccio G, Barone M, Santantonio T, Masetti C, Tundo P, Smedile A, Carretta V, Gatti P, Termite AP, Valvano MR, Bruno G, Fabrizio C, Andreone P, Zappimbulso M, Gaeta GB, Napoli N, Fon


    2017; 12(1): e0168821

    Crohn's Disease Localization Displays Different Predisposing Genetic Variants.

    Palmieri O, Bossa F, Valvano MR, Corritore G, Latiano T, Martino G, D'Incà R, Cucchiara S, Pastore M, D'Altilia M, Scimeca D, Biscaglia G, Andriulli A, Latiano A


    2016; ():

    Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.

    Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, Siena D, Caruso M, Ippolito A, Mannuccio PM, Andriulli A


    2016; :

    A Polymorphism of the Tnf-? Gene Promotes Steroid-Resistance In patients with Inflammatory Bowel Disease

    Palmieri O., Latiano A., Bossa F., Valvano M.R., D'incà R., Corritore G., Latiano T., Andriulli A., Annese V.

    Alimentary pharmacology and therapeutics 2016; ():

    HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.

    Niro GA, Smedile A, Fontana R, Olivero A, Ciancio A, Valvano MR, Pittaluga F, Coppola N, Wedemeyer H, Zachou K, Marrone A, Fasano M, Lotti G, Andreone P, Iacobellis A, Andriulli A, Rizzetto M


    2016; ():

    Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancer.

    Mazzoccoli G, Colangelo T, Panza A, Rubino R, Tiberio C, Palumbo O, Carella M, Trombetta D, Gentile A, Tavano F, Valvano MR, Storlazzi CT, Macchia G, De Cata A, Bisceglia G, Capocefalo D, Colantuoni V, Sabatino L, Piepoli A, Mazza T


    2016; ():

    Transperineal ultrasonography: First level exam in IBD patients with perianal disease.

    Terracciano F, Scalisi G, Bossa F, Scimeca D, Biscaglia G, Mangiacotti M, Valvano MR, Perri F, Simeone A, Andriulli A


    2016; :

    Deregulated expression of cryptochrome genes in human colorectal cancer

    Mazzoccoli G., Colangelo T., Panza A., Rubino A., De Cata A., Tiberio C., Valvano M.R., Pazienza V., Merla G., Augello B., Trombetta D., Storlazzi C.T., Macchia G., Gentile A., Tavano F., Vinciguerra M., Bisceglia G., Rosato V., Colantuoni V., sabatino L.


    2015; 9(1): 52-7

    HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome.

    Andriulli A, Morisco F, Ippolito AM, Di Marco V, Valvano MR, Angelico M, Fattovich G, Granata R, Smedile A, Milella M, Felder M, Gaeta GB, Gatti P, Fasano M, Mazzella G, Santantonio T


    2014; 34(9): 1369-77

    Variation in genes encoding for interferon ?-3 and ?-4 in the prediction of HCV-1 treatment-induced viral clearance.

    Palmieri O, Ippolito AM, Margaglione M, Valvano MR, Gioffreda D, Fasano M, D'Andrea G, Corritore G, Milella M, Andriulli N, Morisco F, Giannitrapani L, Latiano A, Fontana R, Gatti P, Tundo P, Barone M, Cozzolongo R, Santantonio T, Andriulli A


    2014; 46(9): 818-25

    An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C.

    Andriulli A, Nardi A, Di Marco V, Ippolito AM, Gavrila C, Aghemo A, Di Paolo D, Squadrito G, Grassi E, Calvaruso V, Valvano MR, Brancaccio G, Craxi A, Angelico M, Collaborators, Collaborators


    2014; 60: S312

    Hcv genotype 1a and 1b: similarities and differences in clinical features, therapeutic outcome and predictors of response

    F. Morisco, V. Di Marco, R. Granata, S. Camera, Ippolito A, M. Margaglione, G. Fattovich, A. Smedile, E. Clery, C. Ferraiuoli, M. Guarino, L. Donnarumma, Valvano MR, M. Milella, M.M. Felder, G.B. Gaeta, P. Gatti, P. Tundo, M. Barone, R. Cozzolongo, M. Ang

    2014; 60: S456

    A model to estimate a priori the probability of sustained virological response to peg-interferon and ribavirin for patients with hcv-1 infection

    Andriulli A, Angelico M, Nardi, Ippolito A.M., C. Gravila, V. Calvaruso, Valvano M.R., V. Di Marco, A. Craxì.

    2014; 46S: S12

    A model to predict success following peg-interferon and ribavirin therapy for patients with HCV-1 infection

    Ippolito A.M., Andriulli A., Angelico M., Nardi A., Di Marco V., Smedile A., Calvaruso V., Valvano M.R., Milella M., Morisco F., Fattovich G., Felder M., Brancaccio G., Fasano M., Gatti P., Andriulli N., Tundo P., Barone M., Cozzolongo R., D'Andrea G., Ma

    2014; ():

    Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: single centre experience.

    di Mola FF, Tavano F, Rago RR, De Bonis A, Valvano MR, Andriulli A, di Sebastiano P


    2014; ():

    Reply to "Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools"

    Palmieri O, Valvano MR, Margaglione M, Andriulli A


    2014; ():

    Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia.

    Iacobellis A, Cozzolongo R, Minerva N, Valvano MR, Niro GA, Fontana R, Palmieri O, Ippolito A, Andriulli A


    2014; ():

    Can we include genetic variants with high linkage disequilibrium into a multiple logistic model? Author's reply.

    Palmieri O, Valvano MR


    2014; 75(4): 364-9

    Impact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: Association with IL33 gene variant.

    Latiano A, Palmieri O, Bossa F, Latiano T, Corritore G, De Santo E, Martino G, Merla A, Valvano MR, Cuttitta A, Mazza T, Annese V, Andriulli A


    Biochimica et Biophysica Acta 2014; (): 1-12

    Peroxisome proliferator-activated receptor ?-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.

    Panza A, Votino C, Gentile A, Valvano MR, Colangelo T, Pancione M, Merla G, Andriulli A, Sabatino L, Vinciguerra M, Mazzoccoli G, Colantuoni V, Piepoli A


    XVI Congresso Nazionale SIGU 2013; : 15

    MicroRNA-139-5p regulates human TIM expression in colon cancer cell lines

    Panza A., Gentile A., Valvano R., Augello B., Tavano F., Merla G., Guarnieri V., Andriulli A., Mazzoccoli G., Piepoli A.

    XVI Congresso Nazionale SIGU 2013; : P273

    Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin

    Palmieri O., D'andrea G., De Girolamo G., Di Marco V., Margaglione M., Ippolito A.M., Fattovich G., Smedile A., Valvano M.R., Calvaruso V., Gioffreda D., Milella M., Morisco F., Felder M., Brancaccio G., Fasano M., Gatti P., Tundo P., Barone M., Cozzolong

    2013; : S-471

    Genetic Risk Profiling of Complicated Disease Course in Crohn's Disease Patients

    Latiano A., Palmieri O., Buccianti N., Scimeca D., Biscaglia G., Valvano M.R., D'Incà R., Annese V., Andriulli A.

    2013; 45(12): 1003-10

    Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases.

    Tavano F, Palmieri O, di Mola FF, Latiano A, Burbaci FP, Valvano MR, Corritore G, Augello B, Merla G, Annese V, Andriulli A, di Sebastiano P


    Società Italiana di Genetica Umana - XVI Congresso Nazionale 2013; : P321

    The TT/-G frameshift variant of the novel IFNL4 gene not improves HCV1 clearance prediction

    Palmieri O., D'andrea G. , Ippolito A.M., De Girolamo G. , Margaglione M., Latiano A., Valvano M.R., Gioffreda D., Fasano M., Milella M., Morisco F., Montalto G., Gatti P., Tundo P., Barone M., Cozzolongo R., Santantonio T., Andriulli A.

    Journal of the Pancreas 2013; 14(6): 618-25

    Neoadjuvant chemo-radiotherapy for patients with borderline resectable pancreatic cancer: a meta-analytical evaluation of prospective studies.

    Festa V, Andriulli A, Valvano MR, Uomo G, Perri F, Andriulli N, Corrao S, Koch M


    2013; 60(1): 16-21

    Identification of Naïve Hcv-1 Patients with Chronic Hepatitis who may Benefit from Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Marco VD, Margaglione M, Ippolito AM, Fattovich G, Smedile A, Valvano MR, Calvaruso V, Gioffreda D, Milella M, Morisco F, Felder M, Brancaccio G, Fasano M, Gatti P, Tundo P, Barone M, Cozzolongo R, Angelico M, D'Andrea G, Andriulli N, Abate M


    2013; 20(7): 502-9

    Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

    Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A


    2013; 19(9): 1872-9

    Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis: A Randomized, Double-blind Sham-controlled Study.

    Bossa F, Annese V, Valvano MR, Latiano A, Martino G, Rossi L, Magnani M, Palmieri O, Serafini S, Damonte G, De Santo E, Andriulli A


    2013; 8(4): e62144

    Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease.

    Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro TT, Bossa F, Merla G, Augello B, Latiano T, Corritore G, Settesoldi A, Valvano MR, D'Incà R, Stronati L, Annese V, Andriulli A


    2013; 1833(8): 1853-65

    Interplay between SOX9, ?-catenin and PPAR? activation in colorectal cancer.

    Panza A, Pazienza V, Ripoli M, Benegiamo G, Gentile A, Valvano MR, Augello B, Merla G, Prattichizzo C, Tavano F, Ranieri E, Sebastiano PD, Vinciguerra M, Andriulli A, Mazzoccoli G, Piepoli A


    2012; ():

    Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Iacobellis A, Valvano MR, Spirito F, Ippolito A, Bossa F, Terracciano F, Fontana R, Niro G


    2012; 41(8): 1355-6

    Preoperative Biliary Drainage and Surgical Outcome After Pancreaticoduodenectomy

    Di Mola FF, Tavano F, De Bonis A, Grottola T, Tardio M, Valvano MR, Andriulli A, Di Sebastiano P

    PANCREATOLOGY - 44th European Pancreatic Club (EPC) Meeting 2012; : P99

    Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy

    di Mola FF, Tavano F, Rago RR, Tardio M, Valvano MR, di Sebastiano P

    PANCREATOLOGY - 44th European Pancreatic Club (EPC) Meeting 2012; : P81

    Neoadjuvant chemo-radiotherapy for Patients with Borderline Resectable Pancreatic Cancer: A Meta-analytical evaluation of Prospective Studies

    Festa V, Andriulli A, Valvano MR, Uomo G, Perri F, Corrao S, Koch M

    2012; 29(8): 994-1003

    Association Study of a Polymorphism in Clock Gene PERIOD3 and Risk of Inflammatory Bowel Disease.

    Mazzoccoli G, Palmieri O, Corritore G, Latiano T, Bossa F, Scimeca D, Biscaglia G, Valvano MR, D'Incà R, Cucchiara S, Stronati L, Annese V, Andriulli A, Latiano A


    2012; 44(11): 952-6

    A unifying working hypothesis for Juvenile polyposis syndrome and Ménétrier's disease: Specific localization or concomitant occurrence of a separate entity?

    Piepoli A, Mazzoccoli G, Panza A, Tirino V, Biscaglia G, Gentile A, Valvano MR, Clemente C, Desiderio V, Papaccio G, Bisceglia M, Andriulli A


    2012; 6-p448: s187

    Polymorphism in IL-33, IL1RL1 genes and risk of inflammatory bowel disease

    Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro T, Bossa F, Merla G, Augello B, Valvano MR, D'Incà R, Cucchiara S, Annese V, Andriulli A,

    2012; 6(5): 563-70

    Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels.

    Tavano F, di Mola FF, Latiano A, Palmieri O, Bossa F, Valvano MR, Latiano T, Annese V, Andriulli A, di Sebastiano P


    2012; 56: s427

    A substantial proportion of naive HCV-1 infected patients with chronic infection may benefit from current standard therapy with PEG-interferon and ribavirin

    Andriulli A, Valvano MR, Spirito F, Ippolito A, Iacobellis A, Bossa F, Terracciano F, Niro G

    2012; 56: S262

    Hemorrhagic complications following invasive procedures in cirrhotic patients with normal or abnormal coagulopathy. A prospective study

    Napolitano G, Valvano MR, Caruso N, Merla A, Lauriola W, Ippolito A, Siena D, Niro G, Florio F, Andriulli A

    2011; ():

    ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

    Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A


    2011; 6(7): e22688

    Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients.

    Latiano A, Palmieri O, Latiano T, Corritore G, Bossa F, Martino G, Biscaglia G, Scimeca D, Valvano MR, Pastore M, Marseglia A, D'Incà R, Andriulli A, Annese V


    2011; :

    SIRT1 and the Clock Gene Machinery in Colorectal Cancer

    Pazienza V, Piepoli A, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Mazzoccoli M


    2011; 396(3): 345-51

    A modified fast-track program for pancreatic surgery: a prospective single-center experience.

    di Sebastiano P, Festa L, De Bonis A, Ciuffreda A, Valvano MR, Andriulli A, di Mola FF


    2011; 28(10): 841-51

    Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients.

    Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P, Andriulli A, Piepoli A


    2011; 54(4): 605A

    Long-Term Outcome Of Liver Disease In Patients With Hbv-Related Chronic Hepatitis Under Protracted Nucleos(T)Ide Analogs

    Niro GA et al.

    2011; ():

    Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies.

    Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, Maisonneuve P, Sebastiano PD


    2011; 18(7): e206-11

    Unawareness of HBV infection among inpatients in a Southern Italian hospital.

    Ippolito AM, Niro GA, Fontana R, Lotti G, Gioffreda D, Valvano MR, Iacobellis A, Di Mauro L, Stroffolini T, Andriulli A


    {accordionfaq faqid=accordion3 faqclass="lightnessfaq defaulticon headerbackground headerborder contentbackground contentborder round5" active=0}

nuovo-css

webcamlive

Newsletter

Informativa Newsletter
  twitter   facebook   youtube   g plus